Pliant Therapeutics Inc (PLRX)

13.96 -0.11  -0.78% NASDAQ Nov 30, 09:43 USD

Pliant Therapeutics Cash from Investing (TTM):

59.82M for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Cash from Investing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (TTM) Data

View and export this data going back to 2019. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 59.82M
June 30, 2021 -77.36M
March 31, 2021 -187.26M
Dec. 31, 2020 -210.87M
Sept. 30, 2020 -231.95M
June 30, 2020 -113.13M
March 31, 2020 -1.887M
Dec. 31, 2019 -17.93M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Benchmarks

Jaguar Health Inc -10.48M
Progenity Inc -3.466M
RenovoRx Inc --

Cash from Investing (TTM) Range, Past 5 Years

Minimum -231.95M Sep 2020
Maximum 59.82M Sep 2021
Average -97.57M


Top Premarket Gainers
MT Newswires 09/07 08:09 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.